WallStreetZenWallStreetZen

NASDAQ: TVTX
Travere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Travere Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Elizabeth E. ReedChief Legal Officer and GC2026-03-1610,000$19.08
$190.80kBuy
Elizabeth E. ReedChief Legal Officer and GC2026-03-1610,000$28.09
$280.86kSell
Eric M. DubeCHIEF EXECUTIVE OFFICER2026-02-2060,000$30.10
$1.81MSell
Eric M. DubeCHIEF EXECUTIVE OFFICER2026-02-2060,000$15.46
$927.60kBuy
Elizabeth E. ReedChief Legal Officer and GC2026-02-1710,000$19.08
$190.80kBuy
Elizabeth E. ReedChief Legal Officer and GC2026-02-175,679$27.50
$156.20kSell
Elizabeth E. ReedChief Legal Officer and GC2026-02-174,321$28.26
$122.12kSell
Elizabeth E. ReedChief Legal Officer and GC2026-02-04509$32.74
$16.66kSell
Christopher R. ClineCHIEF FINANCIAL OFFICER2026-02-041,635$32.14
$52.55kSell
Christopher R. ClineCHIEF FINANCIAL OFFICER2026-02-04110$32.90
$3.62kSell

1 of 7

TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVTX insiders and whales buy or sell their stock.

TVTX Shareholders

What type of owners hold Travere Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ruth Shepley53.12%49,000,000$1.36BInsider
Janus Henderson Group PLC11.40%10,511,166$291.68MInstitution
Fmr LLC10.43%9,617,863$266.90MInstitution
Blackrock Inc8.53%7,869,352$218.37MInstitution
Vanguard Group Inc6.84%6,309,229$175.08MInstitution
State Street Corp5.16%4,756,666$132.00MInstitution
Perceptive Advisors LLC4.64%4,278,180$118.72MInstitution
Nomura Asset Management International Inc4.09%3,773,564$104.72MInstitution
Armistice Capital LLC4.08%3,763,891$104.45MInstitution
Adage Capital Partners GP LLC3.17%2,927,000$81.22MInstitution

1 of 3

TVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVTX63.78%36.22%Net SellingNet Selling
BEAM86.40%13.60%Net SellingNet Selling
BCRX83.18%15.21%Net SellingNet Buying
RCUS68.34%31.66%Net SellingNet Selling
MAZE88.42%11.58%Net SellingNet Buying
View Top Biotech Stocks

Travere Therapeutics Stock Ownership FAQ

Who owns Travere Therapeutics?

Travere Therapeutics (NASDAQ: TVTX) is owned by 110.79% institutional shareholders, 62.90% Travere Therapeutics insiders, and 0.00% retail investors. Ruth Shepley is the largest individual Travere Therapeutics shareholder, owning 49.00M shares representing 53.12% of the company. Ruth Shepley's Travere Therapeutics shares are currently valued at $1.31B.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.